Search Results 671-680 of 19240 for hemoglobin

1. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   hemoglobin ≥9 g/dL;; serum bilirubin ≤1.5 × upper limit of normal (ULN) or ≤ × ULN for patients with Gilbert's disease;; CrCl ≥30 mL/min as measured by 24 ...

2. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; subjects with hemoglobin ≥ 8-9 g/dL may be included with approval from the Medical Monitor;; In subjects transfused before study entry ...

3. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

   Hemoglobin <11 g/dL. Signs of hemolysis with abnormal values by any of the following hemolytic markers: Increased absolute reticulocyte counts (above ULN); ...

4. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   - Hemoglobin >= 9 g/dL or >= 5.6 mmol/L(within 14 days of registration) - Criteria must be met without packed red blood cell (pRBC) transfusion within the ...

5. A Study Of Ex Vivo Expansion (ACT-X) - Mayo Clinic

   The following laboratory values obtained ≤ 28 days prior to registration. Hemoglobin ≥910.0 g/dl. Absolute neutrophil count (ANC) ≥1500/mm3. Platelet count ...

6. Investigational Trial To Evaluate XC001 Delivered Via An Cardiac Catheter In Subjects With Chronic Angina. - Mayo Clinic

   Body mass index \> 45 kg/m2. 5. Hemoglobin \< 10 g/dL, absolute neutrophil count \< 1.2 × 103 per µL, platelet count \< 75,000 per µL, alanine ...

7. Myelofibrosis - Diagnosis and treatment - Mayo Clinic

   Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.

8. A Study of the Effectiveness of Sulfasalazine in Preventing Acute Diarrhea in Patients with Cancer who are Undergoing Pelvic Radiation Therapy - Mayo Clinic

   Life expectancy ≥ 6 months; Hemoglobin ≥ 10.0 g/dL; Leukocytes ≥ 3,500/mm^3; ANC ≥ 1,500/mm^3; Platelet count ≥ 100,000/mm^3; Creatinine ≤ 1.5 times upper ...

9. Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Hemoglobin > 8.0 gm/dL; Total bilirubin within normal limits. Ejection fraction by MUGA scan or echocardiogram ≥ lower limit of institutional normal ...

10. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

    Hemoglobin ≥ 10 g/dL. Patient must have the ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria.